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Short title: Prediction of Cesarean Delivery in Nulliparas 
Condensation: 
Maternal age, BMI, height, fetal AC and fetal HC can be used to accurately predict the 
risk of Cesarean Delivery in the term nulliparous woman. 
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Abstract 
Background 
In contemporary practice many nulliparous women require intervention during childbirth 
such as operative vaginal delivery or Cesarean delivery (CD).  Despite the knowledge 
that the rising CD rate is associated with increasing maternal age, obesity and larger 
infant birthweight, we lack a reliable method to predict the requirement for such 
potentially hazardous obstetric procedures during labor and delivery. This issue is 
important as there are higher rates of morbidity and mortality associated with unplanned 
CD performed in labor compared to scheduled Cesarean deliveries.  A prediction 
algorithm to identify women at risk of an unplanned CD could help reduced labor 
associated morbidity.  
Objective 
In this primary analysis of the Genesis study, our objective was to prospectively assess 
the use of prenatally determined, maternal and fetal, anthropomorphic, clinical and 
ultrasound features to develop a predictive tool for unplanned CD in the term nulliparous 
woman, prior to the onset of labour. 
Methods 
The Genesis Study recruited 2,336 nulliparous women with a vertex presentation 
between 39+0 and 40+6 weeks’ gestation in a prospective multi-center national study to 
examine predictors of CD. At recruitment a detailed clinical evaluation and ultrasound 
assessment were performed. To reduce bias from knowledge of this data potentially 
influencing mode of delivery, women, midwives and obstetricians were blinded to the 
ultrasound data. All hypothetical prenatal risk factors for unplanned CD were assessed 
as a composite. Multiple logistic regression analysis and mathematical modelling was 
used to develop a risk evaluation tool for CD in nulliparous women. Continuous 
predictors were standardized using z scores.  
Results 
From a total enrolled cohort of 2,336 nulliparous participants, 491 (21%) had an 
unplanned CD. Five parameters were determined to be the best combined predictors of 
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CD. These were advancing maternal age (OR 1·21, 95% CI 1.09-1.34), shorter 
maternal height (OR 1·72, 95% CI 1.52-1.93), increasing BMI (OR 1·29, 95% CI 1.17-
1.43), larger fetal abdominal circumference (AC) (OR 1·23, 95% CI 1.1-1.38) and larger 
fetal head circumference (HC) (OR 1·27, 95% CI 1.14-1.42).  A nomogram was 
developed to provide an individualized risk assessment to predict CD in clinical practice, 
with excellent calibration and discriminative ability (KS, d-statistic 0.29 95% CI 0.28-
0.30) with a misclassification rate of 0.21 (95% CI 0.19-0.25).  
Conclusion 
Five parameters (maternal age, BMI, height, fetal AC and fetal HC) can, in combination, 
be used to better determine the overall risk of CD in nulliparous women at term. A risk 
score can be used to inform women of their individualized probability of CD. This risk 
tool may be useful for reassuring most women regarding their likely success at 
achieving an uncomplicated vaginal delivery as well as selecting those patients with 
such a high risk for CD that they should avoid a trial of labor. Such a risk tool has the 
potential to greatly improve planning hospital service needs and minimizing patient risk. 
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Introduction 
Many nulliparous women undergo emergency obstetric procedures during labor, 
including operative vaginal delivery and cesarean delivery (CD) 1,2.   However, we lack a 
reliable strategy for predicting which women will experience the greatest difficulties 
during labor.  This may be frustrating and disappointing for women and obstetricians 
alike. The issue is important because CD in advanced labor has a higher morbidity (and 
mortality) than an elective pre-labor CD3,4 .  Additionally, there has been increased 
attention on reducing the rates of CD by professional bodies and government agencies 
by introducing policies promoting vaginal delivery, often with little focus on the potential 
consequences of these recommendations5. If obstetricians and midwives could predict 
which women will need an operative delivery in their first labor, increased risk might be 
avoided by offering an elective procedure to those at highest risk, while those at low risk 
could be reassured and encouraged to pursue a vaginal delivery.  
Although many risk factors for CD in nulliparous parturient have been identified, to date 
there has not been an established method for determining the effects of multiple risk 
factors for determining the probability of CD in an individual woman6. This may, in part, 
be attributable to the many indications for performing an emergency or unplanned CD, 
the complex nature of labor dystocia and the interactions of composite risk factors. The 
two principal indications  for primary intrapartum CD in nulliparas are labor dystocia and 
abnormal fetal heart rate patterns, neither of which can be accurately diagnosed until 
there has been a trial of labor7. Indeed, both of these indications for primary CD may be 
present simultaneously in an individual patient. While many studies have tried to predict 
CD by prenatal diagnosis of cephalopelvic disproportion or fetal macrosomia, neither 
strategy has proved useful in the clinical setting 8-10. Others have tried to predict CD 
using neural networks and intrapartum ultrasound but the methodology used is often too 
complex for everyday use 11,12. 
In this primary analysis of the Genesis study, our objective was to prospectively assess 
the use of prenatally determined, maternal and fetal, anthropometric, clinical and 
ultrasound features to develop a predictive tool for unplanned CD in nulliparous women 
at term, before the onset of labor. 
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Materials and Methods 
This was a prospective, multicenter, blinded observational study conducted between 
October 2012 and June 2015. Nulliparous women were invited to participate at each of 
the seven Perinatal Ireland Research Consortium sites (Rotunda Hospital, Dublin; 
National Maternity Hospital, Dublin; Coombe Women and Infants University Hospital, 
Dublin; Galway University Hospital, Galway; University Maternity Hospital, Limerick; 
Cork University Maternity Hospital, Cork; Royal Jubilee Hospital, Belfast). There are 
approximately 70,000 deliveries per year in Ireland with a birth rate of 15 per 1,000 
population across 19 hospitals delivering obstetric care 13. The clinical activity of the 
seven participating sites represents almost 80% of deliveries on the island of Ireland 
and each site is affiliated with a university academic Department of Obstetrics and 
Gynecology. The national cesarean delivery rate in Ireland was 28·2% in 2013 13.  
The study was powered at 90% with a 5% level of significance (two-tailed) to assess the 
performance of a risk prediction model for CD in nulliparous women. An anticipated CD 
rate of 20% in the Robson group 1 and 2 participants (nulliparous patients with a 
singleton pregnancy in a cephalic presentation, who had spontaneous or induced labor 
respectively) was used. This rate was estimated from the clinical activity reports of the 
three largest hospitals included in the study. Since the number of potential predictors 
was not known a priori, the powerlog program for STATA was used to determine the 
sample size and statistical power for a multiple logistic regression model14. Assuming a 
minimum 20% increase in risk for CD (i.e. 24%) for a one standard deviation increase in 
any predictor, the estimated sample size was 2,268. This assumes a moderate 
correlation coefficient of 0.4 among the set of predictors. The study therefore had 
greater power (>90%) in situations with low correlations between the predictors or 
higher risks associated with a one standard deviation increase in a predictor. In the 
event of a lower CD rate at the mean value of a predictor, for example 15%, the study 
had 80% statistical power. 
Inclusion criteria for this study were all nulliparous patients with a singleton, cephalic 
presentation from 39+0 to 40+6 weeks’ gestation with an uncomplicated pregnancy at 
enrolment. All participants had a confirmed estimated date of delivery by either first 
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trimester ultrasound or a second trimester ultrasound which correlated with their 
menstrual dates. Those excluded from participation in the study were multiparas, 
multiple pregnancies, breech presentation, ruptured membranes (at time of study 
ultrasound) and pregnancy complications such as pre-eclampsia, hypertension 
(requiring anti-hypertensive medication), fetal growth restriction, obstetric cholestasis 
and gestational diabetes mellitus (GDM) requiring insulin or oral hypoglycemic agents at 
the time of recruitment. GDM treated with diet alone was not an exclusion criterion. 
Women who had a clinically indicated obstetric ultrasound performed after 34 weeks’ 
gestation for fetal biometry were also excluded from the study to obviate the potential 
influence of late ultrasound-derived fetal size estimates on clinical decision-making 
regarding timing or mode of delivery. Pre-existing medical conditions such as cardiac 
disorders, pre-gestational diabetes mellitus, seizure disorder or bleeding disorders were 
also excluded.  
Institutional Review Board approval was obtained at each of the seven hospitals 
involved in the study. Participant information leaflets were provided at each of the 
research sites in the prenatal clinics and ultrasound departments. Participants either 
self-presented for enrolment in the study or were recruited by a dedicated Perinatal 
Ireland research sonographer at each site from the prenatal clinics. Written informed 
consent was obtained from all women participating in the study. Once recruited a 
research ultrasound was carried out between 39 and 40+6 weeks’ gestation. Baseline 
characteristics were obtained such as age, weight, height, BMI (all obtained at the first 
antenatal visit), gestational weight gain assessed at the study visit, whether or not they 
had been screened for GDM and the screening method, maternal head circumference, 
ethnicity, attendance at prenatal  classes, model of prenatal care, presence of written 
birth plan, medical history, previous history of cervical surgery, family history of CD in a 
first degree relative, marital status, smoking status, alcohol and drug use, employment 
details and highest level of education achieved.  
A study ultrasound examination was performed after 39 completed weeks and prior to 
40 weeks and 6 days. Standard fetal biometry was measured including biparietal 
diameter (BPD), head circumference (HC), abdominal circumference (AC), and femur 
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length (FL), yielding a calculated estimated fetal weight (EFW) using the Hadlock-4 
formula. The fetal head position and engagement were recorded at the time of the study 
ultrasound. Biometric data from this ultrasound examination were not revealed to study 
participants. Managing clinicians and midwives were also blinded to the results of fetal 
biometry, so as to avoid any potential for bias from suspicion of fetal macrosomia 
influencing decisions relating to timing and mode of delivery. A biophysical score was 
performed and documented in the participants medical records.  
Findings of an abnormal biophysical profile (<6/8), a diagnosis of small for gestational 
age or an EFW >5,000 grams were revealed to the study participants and managing 
clinicians, with all such revealed cases being excluded from the study. Standard 
perinatal and obstetric data were collected contemporaneously and included gestational 
age at delivery, onset of labor, use of prostaglandin for pre-induction cervical priming, 
amniotomy, use of oxytocin, maternal fever, type of analgesia used, duration of labor, 
mode of delivery, indication for operative delivery, perineal trauma and blood loss.   
Statistical Analysis 
The primary objective of the statistical analysis was to predict individual absolute risk of 
CD with optimal calibration and discriminative ability. Simple and multiple logistic 
regression analyses were used to model the maternal demographics and ultrasound 
biometry risk factors for CD. Continuous predictors were standardized using z-scores 
(predictor value – mean / standard deviation) to show the relative effects of predictors. 
Pair-wise interaction terms and quadratic effects of variables were included in the set of 
potential predictors. In an analysis of a prediction model there are several areas of 
importance to be considered; the model performance in terms of the accuracy of 
predictions, the prediction error, the overall calibration and internal validation of the 
prediction model. Each of these assessments are outlined in detail here. The Akaike 
Information Criterion (AIC) was used to determine model fit. The AIC is the 
asymptotically equivalent to leave-one out cross-validation (LOOCV) for penalizing 
complexity 15. Validation analyses were performed on the full data (“apparent” model fit) 
in addition to re-sampling methods: full boostrap sampling with replacement (1,000 
repeats) and 10-fold cross-validation (100 repeats). The Brier score, scaled Brier score 
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and Pietra index were considered as overall measures of prediction error16. The 
Hosmer-Lemeshow test and Stukel tests were used to determine adequacy of 
calibration17. In addition, calibration intercept (“calibration-in-the-large”) and calibration 
slope were assessed for potential model re-calibration and presented using smoothed 
loess curves18. Discriminative ability was assessed using the Komogorov-Smirnoff (KS) 
D-statistic, Gini coefficient, AUC c-statistic and the misclassification rate. Different link 
functions and their effect upon calibration were assessed, including the complementary 
log-log and generalized logistic function. Center effects were assessed using stratified 
logistic regression and random-coefficients logistic regression. SAS Version 9.2 was 
used for data management & data screening. SAS PROC LOGISTIC and PROC 
NLMIXED were used for statistical modelling. Stata version 13 and the nomolog 
package was used for the nomogram construction19.  
Results 
The study population profile is described in Table 1. A total of 2,392 study participants 
were recruited. There were 56 (2·3%) participants excluded for the following reasons; 
lost to follow up (n=4), abnormal biophysical profile (n=33), EFW under 2.5kg or over 
5kg (n= 5), EFW performed after enrolment (n=5) and pre-existing indication for CD 
such as breech presentation and placental abruption (n=9). Therefore, a total of 2,336 
women were included in the final analysis, and they represented the cohort of nulliparas 
who underwent a blinded ultrasound evaluation of fetal weight after 39 weeks’ 
gestational age and who were deemed suitable for trial of labor at the time of the final 
ultrasound assessment. 
The average maternal age was 29 +/- 5·1 years and the average maternal BMI was 
24·5 +/- 4·3 kg/m2. Mean maternal gestational weight gain was 13·8 kg +/- 5·3 kg. The 
majority of those enrolled were of European ethnicity (n=2,221, 95·2%). Over half 
(1,215, 52%) attended for obstetrician-provided care with 1,120 (48%) attending 
midwifery-provided services. In relation to preparation for labor, 1,807 (77·4%) attended 
prenatal education classes with 940 (40·3%) preparing a formal written birth plan. The 
majority of the participants had never smoked (1,355, 58%), 774 (33·2%) were ex-
smokers and 206 (8·8%) were current smokers. The highest level of education obtained 
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in this cohort was third level (college or university level) amongst 1,600 (68·6%) 
patients. In this cohort 1,010 (43·2%) were formally tested for GDM.  
Labor and delivery outcomes are outlined in Table 2. The overall CD rate was 21% in 
this study but there was variation from 14·8% to 25·5% according to each site. The risk 
factors for CD identified in the study are listed in supplementary data 1. 
In a multivariate analysis the combined effect of each potential individual risk factor for 
CD was considered and a model was developed which demonstrated that there were 
five parameters which were most important for predicting overall risk of CD. The odds 
ratios for continuous predictors are presented using z scores for standardization. These 
five parameters were advancing maternal age OR 1·21 (95% CI 1·09-1·34), p=0·0005, 
increasing maternal BMI OR 1·29 (95% CI 1·17-1·42) p<0·0001, shorter maternal 
height OR 1·72 (95% CI 1·54-1·92) p<0·0001, larger fetal HC OR 1·27 (95% CI 1·13-
1·42) p=<0·0001 and larger fetal AC OR 1·23 (95% CI 1·1- 1·37) p=0·0004. The best 
combined predictors are outlined in table 3 with the population means and standard 
deviations (SD). These parameters were used to develop a clinically useful nomogram 
(figure 1) to predict an individualized patient risk assessment for CD in nulliparous 
women at term. A worked example is presented in supplementary data 2 (autoslides) 
along with nomogram variable division scores which aid with using the nomogram. 
With respect to internal validation of the prediction model, boostrap re-sampling and 10-
fold cross-validation gave consistent estimates of model fit (supplementary data 3). 
Consequently, no correction of model fit for over-optimism nor shrinkage of parameter 
estimates were performed (original data model or “apparent fit” is presented in table 3 
and figure 2). The Hosmer-Lemeshow and Stukel test’s for lack-of-fit were not 
statistically significant (p-value=0.218 and 0.562, respectively). The Brier score, or 
average quadratic-loss, was 0.14 and had low informative value due to skewness in the 
individual Brier distribution. The Pietra index, an absolute measure of loss, showed that 
the model achieved 37% gain of an error-free model. The AUC was 0.69 and the 
misclassification rate was 21%.  
The calibration curve (figure 2) showed good calibration-in-the-large and approximate 
linearity. There is potential under-estimation and over-estimation of CD rates in the mid-
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range of risk (prediction probabilities 0.30 to 0.40), the potential grey-area of decision-
making. The under-estimation of CD rates in the high probability region (> 0.5) is very 
uncertain – just 3% of the study population lie within this region. The KS discrimination 
curve shows good separation between those with and without CD (KS p-value <0.001). 
Examination of alternative link functions did not improve the fit of the model in terms of 
calibration or discriminative ability. The fit of a generalized logistic link function gave 
lower and upper asymptotes of 7% and 70%, the potential extremes of risk prediction. 
The addition of quadratic and interaction terms did not improve the AIC or prediction 
value of the model. There was significant variation in CD rates across centers (15% - 
25%, chi-square p-value=0.006). However, the addition of center as a factor in the 
multiple logistic regression was just borderline statistically significant (p-value=0.03) 
while a stratified analysis gave similar parameter estimates and discriminative ability to 
the unstratified analysis. The difference in CD rates was primarily due to different 
underlying risk populations, with differences in maternal demographics and fetal 
biometry observed. 
Related to the Hosmer-Lemeshow test and the calibration curve, actual CD rates for 
prediction probability categories are presented in table 4. In the group with the highest 
predicted risk of CD (predicted >50% probability of CD), which represented 2.2% (n=52) 
of the cohort, 56% (n=29) actually underwent a CD. Only 13% (n=7) of women had an 
uncomplicated vaginal delivery in this high risk cohort. In this cohort 28% (n=15) 
required an operative vaginal delivery, 9% (n=5) had an obstetric anal sphincter injury 
and there was one case of a serious shoulder dystocia with a fractured clavicle. Using 
50% as a high risk cut-off for CD the positive likelihood ratio (LR) was 4.92 and the 
negative LR was 0.95.  
Comment 
Principle Findings 
Five parameters were identified as clinically informative in the estimation of overall risk 
of CD in the term nulliparous woman; namely: advancing maternal age, increasing 
maternal BMI, shorter maternal height, larger fetal head circumference and larger fetal 
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abdominal circumference, the latter blinded ultrasound-derived data obtained after 39 
completed weeks’ gestation. All such parameters are either routinely available or easily 
obtainable. These findings are consistent with previous studies on factors contributing to 
rising CD rates, but prior studies have not shown how these can be used in combination 
as a practical test to quantify individual CD risk in the nulliparous woman20-24.  
The association of higher birthweights and CD has been well described in the 
nulliparous population 25. However, prediction of fetal macrosomia by EFW is fraught 
with difficulty due to inaccuracy, especially in the term fetus 26,27. In this study while a 
composite estimation of fetal weight (above the 90th centiles for gestational age) was 
associated with an increased risk of CD, it did not perform as well as individual 
measurements of fetal HC and fetal AC in determining overall CD risk when other 
maternal and obstetric factors were also taken into consideration. It may be that simple 
single measurements perform better at predicting labor outcomes rather than more 
complex mathematical weight equations in the term fetus.   
The blinding of fetal biometry from the participants, the obstetricians and midwives is a 
major strength of this study and contributed to the objectivity of the findings observed in 
this study. Blinding of the fetal biometry controlled for the potential bias of suspected 
fetal macrosomia affecting the decisions about timing and mode of delivery.  There is 
some evidence that knowledge of an ultrasound obtained estimated fetal weight at term 
is a modifiable independent risk factor for CD and the same authors  suggested that 
limiting the use of EFW acquisition at term may reduce the CD rate28. The results from 
our study, in which the obstetricians were blinded from ultrasound-derived estimates of 
fetal size, suggest that while composite fetal biometry alone should not be used to 
predict the risk of CD, the findings would in fact refute the observation that fetal 
biometry alone is a modifiable risk factor. 22 
Nomograms have been used previously in obstetric populations to assess the risk of 
CD. These nomograms focused on predicting the success of trial of vaginal delivery 
after CD. Grobman et al highlighted that there were six factors that were important in 
determining success of VBAC; maternal age, BMI, ethnicity, previous vaginal delivery, 
vaginal delivery since CD and recurrent indication for CD. This assessment was 
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performed at the initial prenatal visit and did not consider the fetal size as part of the risk 
evaluation 29. Others have used nomograms to determine the risk of CD in the presence 
of fetal macrosomia. Mazouni et al retrospectively assessed the risk factors for CD in a 
small cohort (n=246) of women who delivered infants over 4,000grams. They 
discovered four parameters (age, parity, maternal height and previous CD) which were 
important in predicting a CD in the presence of macrosomia 30. It is interesting that both 
of these studies identified age, BMI and height as predictors of CD, similar to what we 
found in our study.  However, neither study examined the nulliparous population or the 
relationship between fetal biometry and risk of CD. Our study shows that a nomogram 
based on easily identifiable demographic and biometric data at term may be a clinically 
useful and simple method for predicting primary CD in nulliparous women. The 
accuracy of the prediction model is good, reflected in the calibration and discrimination 
curves and this model has been extensively internally validated.  
 
Strengths and Weaknesses 
Our study has other strengths including its prospective multi-center design, the blinding 
of clinicians to ultrasound-derived fetal biometry, large sample size, multiple risk factors 
assessed and multiple time points from initial antenatal assessment (maternal age, BMI 
and height) and late third trimester assessment to include fetal biometry. Another 
feature of the study is that the prediction model identified a small proportion with a very 
high risk (>50% or 1 in 2 chance) of CD, 2.2% (n=52). Even when these women 
avoided a Cesarean there was still a very high probability of other adverse outcomes 
associated with the high risk results. However, this study was not powered to detect 
differences in perineal trauma, post-partum hemorrhage or poor neonatal outcomes.  
The average rate of induction for nulliparous patients in Ireland was 30% in 2009 but 
ranged from 18 to 47% nationally 31. The rate of induction of labor was high at 40.5% in 
this cohort. At first analysis this may appear as a weakness of this study, as some 
readers may believe that their own induction rate is lower than this, thereby calling into 
question the generalizability of our findings. However, it must be noted that our study 
focuses on women who were enrolled only beyond 39 weeks’ gestation thus excluding 
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those who spontaneously labored prior to 39 weeks’ gestation. In our cohort the majority 
of women delivered after 40 weeks’ gestation (n=2,027) and this is an additional 
explanation for the relatively high induction rate. Therefore, ours is a reasonable and 
acceptable induction rate, as our study focuses on those nulliparous patients who have 
remained undelivered after 40 weeks’ gestation. Lower quoted induction rates in 
nulliparous patients in other studies tend to include nulliparous patients across all 
gestational ages. 
Another possible weakness of our study is the fact that only 43% of the study population 
underwent a diagnostic test for gestational diabetes. A risk factor-based screening 
approach for GDM is in use at each of the seven centers in Ireland.  It is, therefore, 
possible that there may have been some cases of undiagnosed GDM in the study 
population which may have contributed to the overall CD rate. With an overall CD rate 
of 21% we expect this effect to be small and better reflects current obstetric practice.  
Clinical Implications 
The information garnered from this study should be considered useful for the provision 
of contemporary antenatal care. It can provide an individualized assessment of the risk 
of primary CD which can better inform women in preparation for childbirth and may be 
useful in managing women’s expectations. The identification of women at high risk of 
CD (>50% risk) would also provide the opportunity for informed decision making about 
the potential risks involved in pursuing a vaginal delivery versus an elective CD.   As 
maternal request for CD without specific maternal or fetal indication becomes more 
common, this risk assessment tool may prove useful in perinatal counselling to 
encourage those with a low risk of CD to pursue a vaginal delivery.  
Research Implications 
A recent review of prognostic models in obstetrics highlighted the increasing number of 
prediction models which have been developed but not externally validated32. 
Kleinrouweler et al addressed the need to assess the performance and impact of 
prediction models in clinical practice and expressed concern over the lack of clear 
reporting in the development of prediction models. The information provided in this 
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manuscript contains all of the necessary information for the model to be externally 
validated by other researchers in different populations. Further studies are necessary to 
assess the potential impact of this prediction model. Potential clinical impact studies 
should focus on using this risk assessment tool for CD, to aid in decision making about 
timing and mode of delivery and whether morbidity associated with prolonged labor or 
obstetric interventions can be reduced. 
Conclusion 
This nomogram, using five parameters, (maternal age, BMI, height, fetal head 
circumference and fetal abdominal circumference), has the potential to assist with 
individualized consultation, and thereby optimal selection of women for a successful 
vaginal delivery. It may also serve as an audit tool for improved monitoring of primary 
CD rates in nulliparous women at a hospital or population level. We believe that this risk 
tool will be useful for reassuring most women regarding their likely success at having an 
uncomplicated vaginal delivery as well as selecting those patients with such a high risk 
for CD that they should avoid a trial of labor and the associated morbidity. Such a risk 
tool has the potential to greatly improve planning hospital service needs and minimizing 
patient risk. 
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Table 1. Study Profile 
 
 
      
 
 
   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
3,381 Screened for recruitment 
2,772 Recruited for study 
2,336 included in final analysis 
2,392 Enrolled in study 
 
888(24%) declined to 
participate, were ineligible 
or delivered prior to 
research ultrasound 
 
56 (2.3%) excluded after 
enrolment according to 
pre-specified exclusion 
criteria. 
These 56 are described in 
detail within the text. 
97 (3.5%) excluded due to 
missing data- 283 (10%) 
had a clinically indicated 
ultrasound after 34 weeks’ 
gestation 
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Table 2. Labor and Delivery Outcomes in the Genesis Population 
Outcome Total Percentage 
Spontaneous labor 1,389 59·5% 
Induced labor 947 40·5% 
Method of induction Cervical priming with prostaglandin 670 70·7% 
No cervical priming required 277 29·3% 
Oxytocin use 1,178 49·6% 
Meconium  staining 540 23·1% 
Mode of delivery Spontaneous vaginal delivery 981 41·9% 
Vacuum assisted vaginal delivery 511 21·9% 
Unplanned Cesarean Delivery 491 21·0% 
Forceps assisted vaginal delivery 248 10·6% 
Vacuum followed by Forceps 105 4·5% 
Indication for induction of 
labor 
N=947 
Post-dates (>41 weeks gestation) 522 55·1% 
Prolonged Rupture of Membranes 
(>18 hours- 48 hours)  
157 16·6% 
Suspected Maternal compromise** 154 16·3% 
Suspected Fetal compromise*** 54 5·7% 
Other 35 3·7% 
Not recorded 25 2·6% 
Indication for delivery* 
N=1,355 
i.e. all operative deliveries 
Failure to progress 504 37·2% 
CTG abnormalities 778 57·4% 
Abnormal fetal blood sample 85 6·3% 
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Suspected infection or sepsis 88 6·5% 
Malposition 41 3·0% 
Other 53 3·9% 
Post-partum hemorrhage (estimated and measured blood loss over 
500mls) 
279 11·9% 
Anal sphincter injury 76 3·2% 
Shoulder Dystocia 29 1·2% 
NICU admission 177 7·6% 
 
*Indication for delivery: more than one indication for delivery may have been recorded 
** Suspected maternal compromise included; hypertension, vaginal bleeding, abdominal pain, exhaustion, 
discomfort. 
***Suspected fetal compromise included; suspicious CTG pattern, reduced fetal movements, abnormal 
biophysical score 
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Table 3. Best Combined Predictors of Cesarean Delivery 
 
Results from a multiple logistic regression of z-scores are displayed. Odds-ratios (OR) 
correspond to a +/-1 SD increase/reduction in a predictor. This table can be used to calculate Z 
scores.  
 
 
 
 
 
 
 
 
 
 
 
 
 
Demographic/ 
Ultrasound 
Information 
 
Mean 
 
SD 
 
Odds 
Ratio 
Unit 
At Initial Prenatal Visit At 39+0 to 40+6 weeks 
OR (95% CI) OR (95% CI) 
Age (years) 29.9 5.07 + 1 SD 1.22 (1.10,1.35) 1.21 (1.09,1.34) 
Height (cm) 165.5 6.55 - 1 SD 1.59 (1.43,1.78) 1.72 (1.52,1.93) 
BMI (kg/m2) 24.5 4.27 + 1 SD 1.32 (1.20,1.46) 1.29 (1.17,1.43) 
Fetal HC (mm) 337 12.9 + 1 SD Not applicable 1.27 (1.14,1.42) 
Fetal AC (mm) 351 16 + 1 SD Not applicable 1.23 (1.10,1.38) 
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Table 4. Predicted versus actual Cesarean Delivery Rates 
 
 
 
 
 
 
 
 
 
  
 
 
 
Figure Captions: 
Figure 1. Cesarean Delivery Risk Assessment Tool 
Figure 2. Model Calibration and Discrimination Curves 
Predicted Cesarean Delivery Rate Actual Cesarean Delivery Rate
 
Range (%)
 
Mean (%) within 
Range  
n
 
%
 
< 10%
 
8% 36/348
 
10%
 
10-20%
 
15% 124/935
 
13%
 
20-30%
 
24% 160/614
 
26%
 
30-40%
 
33% 75/258
 
29%
 
40-50%
 
44% 66/127
 
51%
 
> 50%
 
56% 29/52
 
56%
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Figure 1. Cesarean Delivery Risk Assessment Tool 
 
 
 
 
 
 
 
 
 
 
 
 
Example: For a patient aged 35 (score=3.3) with a BMI of 35 (score=3.5), height of 
160cm (score=2.5), fetal HC of 350 (score=5.4), fetal AC of 350 (score=3.8), the total 
score is 18.5 corresponding to a 51% risk of CD. 
M
AN
US
CR
IP
T
 
AC
CE
PT
ED
ACCEPTED MANUSCRIPT
a. Calibration
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Figure 2. Model Calibration and Discrimination 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
D= Discrimination 
LOESS= Locally weighted scatterplot smoothing  
a= LOESS smoothing parameter 
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Glossary of Terms 
Akaike Information Criterion is a method for selecting a statistical model by estimating 
the relative quality of models for a given dataset 
Brier score assess overall performace of a prediction model 
C statistic is a measure of the area under the curve (AUC) in a receiver operating curve 
(ROC) and tells how well a prediction model will work on average 
Gini co-efficeint is a measure of statistical heterogenicity 
Hosmer Lemeshow (goodness-of-fit) test is a statistical method for assessing the 
calibration of a prediction model 
Link functions relate the mean of the response to linear predictors in the model 
Misclassification rate is a measurement error of a prediction model  
Pietra Index is a measure of statistical heterogenicity  
Re-sampling is the statistical process of validating prediction models by using subsets 
of the data. When is the data is selected randomly this is termed bootstrapping. 
Stukel test is another method to assess the goodness of fit or calibration of a prediction 
model 
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Supplementary data 1. Univariate Analysis to Identify Antenatal Factors Associated with Cesarean 
Delivery 
Characteristic Category CD Rate (%) Odds ratio 95% CI p value 
Maternal age (years) <25 16.4 control   
25-35 20.8 1.3 (1.0-1.8) 0.89 
>35 26.6 1.9 (1.3-2.6) <0.001 
Maternal height (cm) >160cm 18.1 control   
<160cm 35.8 2.5 (2.0-3.2) <0.001 
Maternal BMI (kg/m2) <25 17.7 control   
25-30 25.1 1.6 (1.2-1.9) 0.75 
>30 32.5 2.2 (1.7-3.0) <0.001 
Maternal head circumference (cm) <58.2cm 20.0 control   
>58.2cm 29.4 1.7 (1.2-2.2) <0.001 
Ethnicity White European 20.1 control   
Other 28.1 1.5 (1.0-2.3) 0.06 
History of miscarriage No 21.1 control   
Yes 20.1 1.1 (0.7-1.6) 0.77 
Family history of  
Cesarean Delivery 
No 19.5 control   
Yes 25.3 0.72 (0.6-0.9) 0.003 
Birth plan No 19.4 control   
Yes 23.4 1.3 (1.0-1.5) 0.022 
Education level 
(max level achieved) 
Second level 21.0 control   
Third level 21.0 1 (0.8-1.2) 0.95 
Alcohol use (any) in pregnancy No 20.7 control   
Yes 24.7 0.8 (0.6-1.1) 0.20 
Smoking Status Never 22.0 control   
Ex 18.6 0.8 (0.7-1.0) 0.04 
Current 24.0 1.1 (0.8-1.6) 0.22 
Type of care 
 
 
Obstetric provided 21.7 control   
Midwife provided 20.3 0.9 (0.8-1.1) 0.38 
Fetal Head Circumference  <90th centile 20.0 control   
>90th centile 30.0 1.7 (1.3-2.3) <0.001 
Fetal Abdominal Circumference <90th centile 20.1 control   
>90th centile 28.8 1.6 (1.2-2.2) 0.002 
Estimated Fetal Weight <90th centile 19.9 control   
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>90th centile 30.6 1.8 (1.3-2.4) <0.001 
Fetal head engagement on clinical 
palpation 
(at time of study ultrasound) 
Engaged 20.2 control   
Not engaged 21.4 1.1 (0.9-1.3) 0.30 
Uncertain 28.2 1.6 (1.0-2.4) 0.07 
Occiput posterior  
(at time of study ultrasound) 
No 21.5 control   
Yes 19.7 1.1 (0.9-1.4) 0.37 
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Primary Analysis to Develop a 
Mathematical Prediction Model for 
Cesarean Delivery
Unplanned 
Cesarean in a 
Nulliparous 
Woman
Maternal 
Characteristics
Fetal Biometry
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Study Design
• Prospective Observational Blinded Study of 2336 women
• Seven Perinatal Ireland research sites
• Nullipara
• 39+0 to 40+6
• Standard fetal biometry 
• Blinded to the fetal biometry
• Standard perinatal and obstetric data 
• Multivariate analysis to identify best combined 
predictors for Cesarean Delivery
• Development of prediction model and risk assessment 
tool for clinical use
Naomi Burke, Gerry Burke, Michael Turner, Fionnuala Breathnach, Fionnuala McAuliffe, John J Morrison,  Samina Dornan, John Higgins , Amanda Cotter, Michael Geary, 
Peter McParland, Sean Daly, Fiona Cody, Pat Dicker, Elizabeth Tully, Fergal Malone from the Perinatal Ireland Research Consortium Prediction of Cesarean Section AJOG 2017
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Prediction Model
Naomi Burke, Gerry Burke, Michael Turner, Fionnuala Breathnach, Fionnuala McAuliffe, John J Morrison,  Samina Dornan, John Higgins , Amanda Cotter, Michael Geary, 
Peter McParland, Sean Daly, Fiona Cody, Pat Dicker, Elizabeth Tully, Fergal Malone from the Perinatal Ireland Research Consortium Prediction of Cesarean Section AJOG 2017
Demographic
Ultrasound Information
Mean SD OR
Unit
At Initial Booking Visit At 39+0 to 40+6 weeks
OR (95% CI) OR (95% CI)
Age (years) 29.9 5.07 + 1 SD 1.22 (1.10,1.35) 1.21 (1.09,1.34)
Height (cm) 165.5 6.55 - 1 SD 1.59 (1.43,1.78) 1.72 (1.52,1.93)
BMI (kg/m2) 24.5 4.27 + 1 SD 1.32 (1.20,1.46) 1.29 (1.17,1.43)
Fetal HC (mm) 337 12.9 + 1 SD Not applicable 1.27 (1.14,1.42)
Fetal AC (mm) 351 16 + 1 SD Not applicable 1.23 (1.10,1.38)
Results from a multiple logistic regression of z-scores are displayed. 
Odds-ratios (OR) correspond to a +/-1 SD increase in a predictor. 
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Prediction Model
CD= Cesarean Delivery
D= Discrimination
LOESS= Locally weighted scatterplot smoothing 
a=0.05 Large LOESS
a= 0.20 Approximate LOESS
Naomi Burke, Gerry Burke, Michael Turner, Fionnuala Breathnach, Fionnuala McAuliffe, John J Morrison,  Samina Dornan, John Higgins , Amanda Cotter, Michael Geary, 
Peter McParland, Sean Daly, Fiona Cody, Pat Dicker, Elizabeth Tully, Fergal Malone from the Perinatal Ireland Research Consortium Prediction of Cesarean Section AJOG 2017
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Peter McParland, Sean Daly, Fiona Cody, Pat Dicker, Elizabeth Tully, Fergal Malone from the Perinatal Ireland Research Consortium Prediction of Cesarean Section AJOG 2017
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Example
• 35 year old, nulliparous, with a height of 160cm 
and BMI 35. The fetal HC is 350mm and the fetal AC 
is 350mm
• Risk scores from the nomogram 35 years (3.3), BMI 
35 (3.5), height 160cm (2.5), fetal HC 350mm (5.4), 
fetal AC 350 (3.8). Total score is 18.5 which 
corresponds to a 51% risk of cesarean delivery.
Naomi Burke, Gerry Burke, Michael Turner, Fionnuala Breathnach, Fionnuala McAuliffe, John J Morrison,  Samina Dornan, John Higgins , Amanda Cotter, Michael Geary, 
Peter McParland, Sean Daly, Fiona Cody, Pat Dicker, Elizabeth Tully, Fergal Malone from the Perinatal Ireland Research Consortium Prediction of Cesarean Section AJOG 2017
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Age
(years)
BMI
(kg/m2)
Height
(cm)
Fetal HC
(mm)
Fetal AC
(mm)
Value Score Value Score Value Score Value Score Value Score
20 0.0 25 0.0 165 0.0 300 0.0 300 0.0
25 1.1 30 1.8 160 2.5 310 1.1 310 0.8
30 2.2 35 3.5 155 5.0 320 2.1 320 1.5
35 3.3 40 5.3 150 7.5 330 3.2 330 2.3
40 4.4 45 7.0 145 10.0 340 4.3 340 3.0
350 5.4 350 3.8
360 6.4 360 4.5
Nomogram Variable Division Scores
Naomi Burke, Gerry Burke, Michael Turner, Fionnuala Breathnach, Fionnuala McAuliffe, John J Morrison,  Samina Dornan, John Higgins , Amanda Cotter, Michael Geary, 
Peter McParland, Sean Daly, Fiona Cody, Pat Dicker, Elizabeth Tully, Fergal Malone from the Perinatal Ireland Research Consortium Prediction of Cesarean Section AJOG 2017
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Supplementary Data 3. Cross-validation & Boostrap Results 
Means and 95% confidence intervals1 
 
Model Fit Statistic Apparent 
Fit 
 
10-fold Cross-validation 
(Repeats=100) 
Bootstrap Resampling 
(Repeats=1000) 
Training 
Sample 
(9/10
th 
) 
Validation 
Sample 
(1/10
th
) 
Training 
(Bootstrap) 
Sample 
Validation 
(Original) 
Sample 
Cesarean Delivery Rate 0.21 0.21 (0.21, 0.22) 0.21 (0.16, 0.26) 0.21 (0.19, 0.23) 0.21 
Predictor correlation
2 
 0.17 0.17 (0.16, 0.18) 0.19 (0.11, 0.28) 0.17 (0.14, 0.20) 0.17 
Parameter Estimates 
Intercept -1.46 -1.46 (-1.50, -1.42) N/A -1.47 (-1.58, -1.35) N/A 
Maternal age (z-score) 0.19 0.19 (0.15, 0.22) N/A 0.19 (0.08, 0.29) N/A 
Maternal BMI (z-score) 0.26 0.26 (0.22, 0.29) N/A 0.26 (0.16, 0.36) N/A 
Maternal height (z-score) 0.54 0.54 (0.50, 0.58) N/A 0.54 (0.42, 0.66) N/A 
AC (z-score) 0.20 0.20 (0.17, 0.24) N/A 0.21 (0.09, 0.32) N/A 
HC (z-score) 0.24 0.24 (0.20, 0.27) N/A 0.23 (0.13, 0.35) N/A 
Goodness-of-fit 
AIC 2235 2004 (1962, 2045) 225 (182, 266) 2222 (2117, 2330) 2231 (2228, 2239) 
Hosmer-Lemeshow χ2 (8 df) 10.7 8.77 (4.40, 14.65) 8.33 (2.40, 17.20) 17.75 (5.35, 35.75) 9.98 (4.80, 17.40) 
Stukel χ2 (2 df) 1.2 1.34 (0.10, 3.55) 1.58 (0.10, 6.60) 3.36 (0.10, 13.00) 1.56 (0.10, 4.35) 
Overall Performance 
Brier Score 0.14 0.15 (0.15, 0.16) 0.15 (0.13, 0.18) 0.15 (0.14, 0.16) 0.15 (0.15, 0.15) 
Scaled Brier Score 0.15 0.08 (0.07, 0.09) 0.07 (-0.00, 0.14) 0.08 (0.06, 0.11) 0.08 (0.07, 0.08) 
Pietra Score 0.37 0.27 (0.26, 0.28) 0.28 (0.24, 0.34) 0.27 (0.23, 0.31) 0.27 (0.23, 0.31) 
Calibration 
Intercept N/A N/A -0.01 (-0.38, 0.32) N/A 0.00 (-0.10, 0.11) 
Slope N/A N/A 1.00 (0.51, 1.59) N/A 0.98 (0.84, 1.15) 
Discrimination 
D-statistic (KS) 0.34 0.29 (0.27, 0.31) 0.33 (0.20, 0.45) 0.30 (0.25, 0.35) 0.29 (0.28, 0.30) 
Gini coefficient 0.37 0.37 (0.36, 0.39) 0.37 (0.21, 0.53) 0.38 (0.32, 0.43) 0.37 (0.36, 0.37) 
c-statistic (AUC) 0.69 0.69 (0.68, 0.70) 0.68 (0.60, 0.76) 0.69 (0.66, 0.72) 0.68 (0.68, 0.69) 
Misclassification rate 0.21 0.21 (0.20, 0.21) 0.21 (0.16, 0.25) 0.21 (0.19, 0.22) 0.21 (0.21, 0.21) 
Notes.  
1
95% confidence intervals are the 2.5
th
 and 97.5
th
 percentiles of the sampling distribution. To illustrate 
the range of cross-validation findings, the sampling distribution includes both folds and replications 
from each cross-validation (10 x 100= 1000 samples).  
2
 The “predictor correlation” is the maximum multiple correlation among predictors for each sample. 
 
